Allianz Life Insurance Co of New York Files SEC Form POS AM, Post-effective Amendments For Registration Statement (Jan. 17, 2017)
Insurance Weekly News
By a News Reporter-Staff News Editor at Insurance Weekly News -- According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange Commission (SEC) filing by Allianz Life Insurance Co of New York (Form POS AM) was posted on January 17, 2017.
The SEC file number is 0000080019-17-000002.
The contact information for this company is 5701 GOLDEN HILLS DRIVE, GOLDEN VALLEY MN 55308, 800-950-5872.
Our editors provided additional information about Form POS AM: Post-effective amendments.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
Reports from University of Toronto Add New Data to Findings in Risk Management (Modelling the impact of causal and non-causal factors on disruption…
North Texans heading to Friday’s March for Life in Washington
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- LTC riders: More education is needed, NAIFA president says
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
- EIOPA FLAGS FINANCIAL STABILITY RISKS RELATED TO PRIVATE CREDIT, A WEAKENING DOLLAR AND GLOBAL INTERCONNECTEDNESS
More Life Insurance News